Advertisement

Prevalence of the Metabolic Syndrome Among U.S. Adolescents Using the Definition From the International Diabetes Federation

  1. Earl S. Ford, MD, MPH,
  2. Chaoyang Li, MD, PHD,
  3. Guixiang Zhao, MD, PHD,
  4. William S. Pearson, PHD and
  5. Ali H. Mokdad, PHD
  1. From the Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
  1. Address correspondence and reprint requests to Earl Ford, MD, MPH, Centers for Disease Control and Prevention, 4770 Buford Highway, MS K66, Atlanta, GA 30341. E-mail: eford{at}cdc.gov

Abstract

OBJECTIVE—Our objective was to estimate the prevalence of the metabolic syndrome using the 2007 pediatric International Diabetes Federation (IDF) definition among adolescents in the U.S.

RESEARCH DESIGN AND METHODS—We used data from 2,014 participants aged 12–17 years of the National Health and Nutrition Examination Survey 1999–2004.

RESULTS—The prevalence of the metabolic syndrome for the period 1999–2004 was ∼4.5% (∼1.1 million adolescents aged 12–17 years in 2006). It increased with age, was higher among males (6.7%) than females (2.1%) (P = 0.006), and was highest among Mexican-American adolescents (7.1%). The prevalence of the metabolic syndrome was relatively stable across the 6-year period: 4.5% for 1999–2000, 4.4–4.5% for 2001–2002, and 3.7–3.9% for 2003–2004 (P for linear trend >0.050).

CONCLUSIONS—Our results provide the first estimates of the prevalence of the metabolic syndrome using the pediatric IDF definition among adolescents in the U.S.

Footnotes

  • Published ahead of print at http://care.diabetesjournals.org on 10 December 2007. DOI: 10.2337/dc07-1030.

    The findings and conclusions in this article are those of the authors and do not represent the views of the Centers for Disease Control and Prevention.

    The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C Section 1734 solely to indicate this fact.

    • Accepted November 30, 2007.
    • Received May 30, 2007.
| Table of Contents

This Article

  1. Diabetes Care March 2008 vol. 31 no. 3 587-589
  1. All Versions of this Article:
    1. dc07-1030v1
    2. 31/3/587 most recent
Advertisement